ONESOURCE SPECIALTY PHARMA
Back to Income Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,445 Cr | ₹172 Cr | ₹39 Cr | ₹128 Cr | ₹128 Cr |
What is the latest Revenue of ONESOURCE SPECIALTY PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,445 Cr |
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹128 Cr |
How is Revenue of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,445 Cr | 740.43 | |
| Mar2025 | ₹172 Cr | 344.07 | |
| Mar2024 | ₹39 Cr | -69.80 | |
| Mar2023 | ₹128 Cr | 0.00 | |
| Mar2022 | ₹128 Cr | - | |
Compare Revenue of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,141.5 Cr | 1.2% | 2.9% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 1.2% |
2.9% |
-14.6% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses